‘World-first’ vaccine designed by artificial intelligence

• AI-designed vaccine successfully tested in clinical trials, marking the first human evaluation of an artificially-designed immunisation
• Demonstrates potential for computational methods to accelerate vaccine development beyond traditional design approaches
• Opens pathway for faster vaccine creation to respond to emerging infectious disease threats

Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.